8-K: Sonoma Pharma Adopts Rights Plan to Protect NOLs

Sonoma Pharmaceuticals, Inc. has adopted a Section 382 Rights Agreement to preserve its net operating loss carryforwards and other tax benefits.

Summary

• Sonoma Pharmaceuticals, Inc. has entered into a new Section 382 Rights Agreement with Computershare Inc., effective October 6, 2026.
• This agreement replaces a previous one that expired on October 18, 2026.
• The primary purpose is to protect the company's Net Operating Loss (NOL) carryforwards and other tax benefits from limitations that could arise from an 'ownership change' as defined by Section 382 of the Internal Revenue Code.
• A dividend of one preferred stock purchase right (Right) is declared for each outstanding share of common stock as of October 13, 2026.
• Each Right allows the holder to purchase one one-thousandth of a share of Series B Preferred Stock for $10.00, subject to adjustments.
• The Rights become exercisable if a person or group acquires 4.99% or more of the company's common stock, or if a 'Grandfathered Person' exceeds their ownership threshold.
• The company has the option to redeem the Rights for $0.0001 per Right before an 'ownership change' occurs.
• The Rights will expire on October 6, 2036, unless earlier redeemed or if tax benefits expire or are exhausted.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, as it's a proactive measure to preserve valuable tax assets, which is a prudent corporate governance action.

Positives

• Proactive measure to preserve significant tax assets (NOLs) which can reduce future tax liabilities.
• The Rights Agreement is designed to prevent an 'ownership change' that could severely limit the use of these valuable tax benefits.
• The company is taking steps to protect shareholder value by safeguarding a potentially substantial asset.
• The terms allow for exemptions for certain persons or transactions if deemed in the company's best interest and not jeopardizing tax benefits.

Negatives

• The adoption of a 'poison pill' or rights plan can sometimes be perceived negatively by investors as a defensive measure against potential takeovers, although this plan is specifically for tax asset protection.
• The complexity of the Rights Agreement and its definitions (e.g., 'Acquiring Person', 'Grandfathered Person') can be difficult for average investors to fully understand.
• The potential for Rights to become null and void if owned by an 'Acquiring Person' could lead to dilution for such parties.

Risks

• If an 'ownership change' occurs despite the Rights Agreement, the company's ability to utilize its NOLs and other tax benefits will be substantially limited.
• The effectiveness of the Rights Agreement depends on the Board's ability to manage its provisions and make timely determinations regarding exemptions and acquisitions.
• The definition of an 'Acquiring Person' is set at 4.99%, which could be triggered by relatively small increases in ownership.
• The Rights Agreement has an expiration date of October 6, 2036, after which the tax benefits may no longer be protected by this mechanism.

Future Outlook

The company's future outlook is indirectly impacted by the preservation of its NOLs and tax benefits, which could significantly reduce future tax liabilities and improve profitability if the company becomes profitable. The Rights Agreement itself does not provide specific financial guidance but aims to protect existing tax assets.

Management Comments

• The Board adopted the Rights Agreement to protect shareholder value by guarding against a potential limitation on our ability to use our net operating loss carryforwards, or NOLs, and other tax benefits, which may be used to reduce potential future income tax obligations.
• We have experienced and continue to experience substantial operating losses, and under the Internal Revenue Code of 1986, as amended, and rules promulgated thereunder, we may carry forward these NOLs and other tax benefits in certain circumstances to offset any current and future earnings and thus reduce our income tax liability, subject to certain requirements and restrictions.
• To the extent that the NOLs and other tax benefits do not otherwise become limited, we believe that we will be able to carry forward a significant amount of NOLs and other tax benefits, and therefore these NOLs and other tax benefits could be a substantial asset to us.
• However, if we experience an ownership change, as defined in Section 382 of the Code, our ability to use our NOLs and other tax benefits will be substantially limited.

Industry Context

StockSavvy.ai notes that the adoption of Section 382 Rights Agreements is a common strategy for companies with significant net operating losses (NOLs) to protect these valuable tax assets from being limited by IRS rules following an ownership change. Many companies in industries with prolonged periods of unprofitability, such as biotechnology or technology, utilize such plans.

Comparison to Industry Standards

• Many biotechnology and technology companies with substantial NOLs, such as Sorrento Therapeutics (SRNE) in the past, have implemented similar Section 382 Rights Plans to preserve their tax assets.
• The 4.99% ownership threshold for triggering the Rights Plan is a standard benchmark in the industry, designed to prevent hostile takeovers while allowing for passive investment.
• The structure of the Series B Preferred Stock, with its voting and economic equivalence to common stock on a per-share basis (adjusted by the 'Formula Number'), is typical for preferred stock issued under such rights plans.
• The redemption price of $0.0001 per Right is also a common feature, allowing the company to easily terminate the plan if it is no longer needed or if a favorable transaction occurs.

Corporate Governance

Stakeholder Impact

• Shareholders: The Rights Plan is intended to protect shareholder value by preserving NOLs. However, it may also deter unsolicited takeover bids.
• Company Management: The plan provides management with a tool to manage potential ownership changes that could limit tax benefits.
• IRS: The plan is designed to comply with Section 382 regulations, aiming to maintain the usability of NOLs for tax purposes.

Next Steps

• The company will issue Rights to shareholders of record on October 13, 2026.
• The Rights will be evidenced by common stock certificates until the Distribution Date.
• Separate Right Certificates will be issued after the Distribution Date.
• The Board will monitor ownership levels to detect potential 'Acquiring Persons'.
• The company may redeem the Rights at any time before an ownership change occurs.
• The Rights will expire on October 6, 2036, or earlier if tax benefits are exhausted or repealed.

Key Dates

Recommendation

The filing details the adoption of a Section 382 Rights Agreement, a defensive measure primarily aimed at preserving Net Operating Losses (NOLs) and other tax benefits. While this is a prudent step for corporate governance and protecting potential future value, it does not directly indicate current operational performance or immediate catalysts for significant stock price appreciation or depreciation. Therefore, a 'hold' recommendation is appropriate, pending further operational or financial updates from the company.

Keywords

Section 382 Rights Agreement, Net Operating Loss (NOL), Tax Benefits Preservation, Ownership Change, Preferred Stock, Shareholder Value, Corporate Governance, Acquiring Person